Parametric Portfolio Associates’s Cytokinetics CYTK Stock Holding History

Parametric Portfolio Associates’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$9.25M	Sell	251,287 -17,299	-6%	-$615K	﹤0.01%	1410
2021 Q4	$12.2M	Buy	268,586 +11,896	+5%	+$459K	0.01%	1255
2021 Q3	$9.17M	Buy	256,690 +84,307	+49%	+$2.48M	0.01%	1419
2021 Q2	$3.41M	Buy	172,383 +5,778	+3%	+$136K	﹤0.01%	2120
2021 Q1	$3.88M	Buy	166,605 +10,396	+7%	+$222K	﹤0.01%	2339
2020 Q4	$3.25M	Buy	156,209 +1,893	+1%	+$34.6K	﹤0.01%	2361
2020 Q3	$3.34M	Sell	154,316 -33,645	-18%	-$787K	﹤0.01%	2165
2020 Q2	$4.43M	Buy	187,961 +65,348	+53%	+$1.23M	﹤0.01%	1956
2020 Q1	$1.45M	Buy	122,613 +21,680	+21%	+$277K	﹤0.01%	2578
2019 Q4	$1.07M	Sell	100,933 -15,420	-13%	-$158K	﹤0.01%	3029
2019 Q3	$1.32M	Buy	116,353 +11,783	+11%	+$148K	﹤0.01%	2878
2019 Q2	$1.18M	Buy	104,570 +25,783	+33%	+$249K	﹤0.01%	2970
2019 Q1	$637K	Sell	78,787 -3,267	-4%	-$24K	﹤0.01%	3228
2018 Q4	$519K	Buy	82,054 +21,024	+34%	+$154K	﹤0.01%	3294
2018 Q3	$601K	Buy	61,030 +26,651	+78%	+$214K	﹤0.01%	3345
2018 Q2	$285K	Sell	34,379 -11,089	-24%	-$92.3K	﹤0.01%	3571
2018 Q1	$327K	Buy	45,468 +20,263	+80%	+$174K	﹤0.01%	3540
2017 Q4	$205K	Sell	25,205 -11,882	-32%	-$135K	﹤0.01%	3746
2017 Q3	$538K	Buy	37,087 +14,072	+61%	+$192K	﹤0.01%	3381
2017 Q2	$278K	Buy	23,015 +9,682	+73%	+$135K	﹤0.01%	3667
2017 Q1	$171K	Buy	13,333 +189	+1%	+$2.21K	﹤0.01%	3628
2016 Q4	$160K	Sell	13,144 -56	-0.4%	-$594	﹤0.01%	3639
2016 Q3	$121K	Sell	13,200 -996	-7%	-$10.4K	﹤0.01%	3652
2016 Q2	$135K	Sell	14,196 -54,925	-79%	-$451K	﹤0.01%	3688
2016 Q1	$487K	Buy	69,121 +43,405	+169%	+$317K	﹤0.01%	3346
2015 Q4	$269K	Buy	25,716 +7,594	+42%	+$74.5K	﹤0.01%	3604
2015 Q3	$121K	Buy	18,122 +804	+5%	+$5.49K	﹤0.01%	3169
2015 Q2	$116K	Sell	17,318 -34	-0.2%	-$223	﹤0.01%	3858
2015 Q1	$118K	Buy	17,352 +2,622	+18%	+$19.6K	﹤0.01%	3839
2014 Q4	$118K	Buy	+14,730	New	+$63.2K	﹤0.01%	3887